ArticleDrugs in R&D2025

Comparative Preclinical Evaluation of Tuznue Versus Referent Herceptin: A Registered Trastuzumab Biosimilar.

Herve Bischoff et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.